Detalles de la búsqueda
1.
A phase 1 study evaluating the safety and tolerability of otlertuzumab, an anti-CD37 mono-specific ADAPTIR therapeutic protein in chronic lymphocytic leukemia.
Blood
; 123(9): 1302-8, 2014 Feb 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-24381226
2.
Pharmacokinetic and pharmacodynamic properties of TRU-015, a CD20-directed small modular immunopharmaceutical protein therapeutic, in patients with rheumatoid arthritis: a Phase I, open-label, dose-escalation clinical study.
Clin Ther
; 30(10): 1806-16, 2008 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-19014836
3.
Characterization of a proapoptotic antiganglioside GM2 monoclonal antibody and evaluation of its therapeutic effect on melanoma and small cell lung carcinoma xenografts.
Cancer Res
; 65(14): 6425-34, 2005 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-16024647
4.
MOR209/ES414, a Novel Bispecific Antibody Targeting PSMA for the Treatment of Metastatic Castration-Resistant Prostate Cancer.
Mol Cancer Ther
; 15(9): 2155-65, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27406985
Resultados
1 -
4
de 4
1
Próxima >
>>